Hydrophilic bile salt ursodeoxycholic acid protects myocardium against reperfusion injury in a PI3K/Akt dependent pathway
- 1 November 2005
- journal article
- research article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 39 (5) , 766-776
- https://doi.org/10.1016/j.yjmcc.2005.07.014
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 31 references indexed in Scilit:
- Transient Mitochondrial Permeability Transition Pore Opening Mediates Preconditioning-Induced ProtectionCirculation, 2004
- New directions for protecting the heart against ischaemia–reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathwayCardiovascular Research, 2004
- Protein kinase activation and myocardial ischemia/reperfusion injuryCardiovascular Research, 2004
- Adrenomedullin Infusion Attenuates Myocardial Ischemia/Reperfusion Injury Through the Phosphatidylinositol 3-Kinase/Akt-Dependent PathwayCirculation, 2004
- Mitochondrial permeability transition-pore inhibition enhances functional recovery after long-time hypothermic heart preservationTransplantation, 2003
- Cellular and Molecular Dissection of Reperfusion InjuryCirculation Research, 2000
- Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formationCell Death & Differentiation, 1999
- A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation.Journal of Clinical Investigation, 1998
- The mitochondrial permeability transitionBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995
- Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trialJournal of Hepatology, 1993